Page last updated: 2024-09-02

fingolimod hydrochloride and n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide

fingolimod hydrochloride has been researched along with n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide in 1 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)
Trials
(fingolimod hydrochloride)
Recent Studies (post-2010)
(fingolimod hydrochloride)
Studies
(n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide)
Trials
(n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide)
Recent Studies (post-2010) (n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide)
2,7711572,062109011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fauser, U; Schluesener, HJ; Zhang, Z; Zhang, ZY1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide

ArticleYear
FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves.
    Experimental neurology, 2008, Volume: 210, Issue:2

    Topics: Animals; Body Weight; CD3 Complex; Disease Models, Animal; Ectodysplasins; Fingolimod Hydrochloride; Flow Cytometry; Immunosuppressive Agents; Lymphocytes; Macrophages; Male; Neuritis, Autoimmune, Experimental; Propylene Glycols; Rats; Rats, Inbred Lew; Sciatic Nerve; Sphingosine; Sulfonamides

2008
chemdatabank.com